BSECompany Update12 Oct 2026 · 12 Oct 2026, 05:00 pm
Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
Fredun Pharmaceuticals Ltd · 539730
✦ AI Summary
Fredun Pharmaceuticals Ltd has submitted a certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment1/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018